642 related articles for article (PubMed ID: 19948625)
1. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL
Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
Marcus RN; Owen R; Kamen L; Manos G; McQuade RD; Carson WH; Aman MG
J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1110-1119. PubMed ID: 19797985
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Findling RL
J Clin Psychiatry; 2011 Sep; 72(9):1270-6. PubMed ID: 21813076
[TBL] [Abstract][Full Text] [Related]
4. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.
Aman MG; Kasper W; Manos G; Mathew S; Marcus R; Owen R; Mankoski R
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):415-22. PubMed ID: 20973712
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Corey-Lisle PK; Aman MG
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):229-36. PubMed ID: 21663425
[TBL] [Abstract][Full Text] [Related]
6. Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.
Varni JW; Handen BL; Corey-Lisle PK; Guo Z; Manos G; Ammerman DK; Marcus RN; Owen R; McQuade RD; Carson WH; Mathew S; Mankoski R
Clin Ther; 2012 Apr; 34(4):980-92. PubMed ID: 22444782
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.
Findling RL; Mankoski R; Timko K; Lears K; McCartney T; McQuade RD; Eudicone JM; Amatniek J; Marcus RN; Sheehan JJ
J Clin Psychiatry; 2014 Jan; 75(1):22-30. PubMed ID: 24502859
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.
Mankoski R; Stockton G; Manos G; Marler S; McQuade R; Forbes RA; Marcus R
J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):572-6. PubMed ID: 24138011
[TBL] [Abstract][Full Text] [Related]
9. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
11. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.
Findling RL; Correll CU; Nyilas M; Forbes RA; McQuade RD; Jin N; Ivanova S; Mankoski R; Carson WH; Carlson GA
Bipolar Disord; 2013 Mar; 15(2):138-49. PubMed ID: 23437959
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH
Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.
Curran MP
Paediatr Drugs; 2011 Jun; 13(3):197-204. PubMed ID: 21500873
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder.
Findling RL; Youngstrom EA; McNamara NK; Stansbrey RJ; Wynbrandt JL; Adegbite C; Rowles BM; Demeter CA; Frazier TW; Calabrese JR
J Clin Psychiatry; 2012 Jan; 73(1):57-63. PubMed ID: 22152402
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
18. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.
Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y
Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.
Stigler KA; Diener JT; Kohn AE; Li L; Erickson CA; Posey DJ; McDougle CJ
J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):265-74. PubMed ID: 19519261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
